GI Panel

ZeptoMetrix external controls have demonstrated performance on a variety of molecular assays. The product has been tested with the BioFire® FilmArray® system and provides the expected results, however performance characteristics must be established by the end user.

NATtrol GI Panel includes 22 targets: C. coli Clinical isolate; P. shigelloides strain Z130; C. difficile strain NAP1; C. jejuni Clinical isolate; S. enterica typhimurium strain Z005; C. parvum strain Iowa; S. sonnei strain Z004; E. coli strains 7.1493, O84:H28, EPEC; E. coli strains 92.0147, EAEC; V. cholerae strain Z133, nontoxigenic; E. coli strains EDL933, O157; Y. enterocolitica Clinical isolate; E. coli strains ETEC, ST+, LT+; E. histolytica strain DS4-868; G. lamblia strain H3; C. cayetanensis Recombinant; Adenovirus Type 41 strain TAK; Astrovirus Recombinant; Norovirus GI Recombinant; Norovirus GII Recombinant; Rotavirus strain Wa; and Sapovirus Recombinant.

• Formulated with purified, intact organisms

• Organisms are chemically modified to render them noninfectious

• Refrigerator stable—store between 2 and 8°C

• Purified protein matrix treated with 0.09% sodium azide

• 22 x 0.25 mL vials NATtrol GI targets and 4 x 0.85 mL vials of the negative matrix

NATtrol products are ready-to-use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel and to monitor assay-kit lot performance. NATtrol products contain intact organisms and should be run in a manner similar to clinical specimens.

• ENGLISH (SDS)
• ENGLISH (PI)

For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.

When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.